Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...

Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop ...

JAKARTA, Indonesia and NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) -- (LeaderMed), a global pharmaceutical development company, and Combiphar, a leading Indonesian pharmaceutical company in Southeast ...

Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard Jørgensen over the high price of the company’s diabetes and obesity drugs, Ozempic ...

Roche’s current pharmaceutical portfolio will deliver growth through at least 2027, the company said. Schinecker has already ...

Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes.

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ...

As of 2020, the United States’ obesity epidemic impacts over 40% of the adult population. Although the CDC recognized this highly prevalent and serious ...

The End of Obesity Blu-ray and DVD release date for the latest TV special of the long-running adult animated sitcom. This ...